Recent years have witnessed significant progresses in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as hopeful https://emiliazvfe295243.blogofchange.com/39634438/novel-therapeutic-targets-in-diabetes-retatrutide-and-trizepatide